A5102755347- Coronary Interventions and Diagnostics
- Cardiac Imaging and Diagnostics
- Acute Myocardial Infarction Research
- Peripheral Artery Disease Management
- Cardiac Valve Diseases and Treatments
- Vascular Procedures and Complications
- Venous Thromboembolism Diagnosis and Management
- Cerebrovascular and Carotid Artery Diseases
- Infective Endocarditis Diagnosis and Management
- Cardiovascular Function and Risk Factors
- Antiplatelet Therapy and Cardiovascular Diseases
- Cardiovascular Health and Disease Prevention
- Cardiovascular Disease and Adiposity
- Aortic Disease and Treatment Approaches
- Aortic aneurysm repair treatments
- Cardiac, Anesthesia and Surgical Outcomes
- Cardiac Structural Anomalies and Repair
- Lipoproteins and Cardiovascular Health
- Atrial Fibrillation Management and Outcomes
- Infectious Aortic and Vascular Conditions
- Atherosclerosis and Cardiovascular Diseases
- Diabetic Foot Ulcer Assessment and Management
- Cardiac tumors and thrombi
- Carcinogens and Genotoxicity Assessment
- Adipokines, Inflammation, and Metabolic Diseases
Seoul Veterans Hospital
2008-2024
MedStar Washington Hospital Center
2015-2018
Kwangju Christian Hospital
2016
Washington Hospital
2015
Kyung Hee University Dental Hospital
2013-2014
Korea University Medical Center
2014
Soonchunhyang University
2014
Chonnam National University Hospital
2009-2012
Chonnam National University
2009
The progression and development of congestive heart failure is still considered a large problem despite the existence revascularization therapies optimal, state-of-the-art medical services. An acute myocardial infarction (AMI) major cause failure, so researchers are investigating techniques to complement primary percutaneous coronary intervention (PCI) or thrombolytic therapy prevent after AMI. Twenty-six patients with successful PCI for ST-segment elevation anterior wall were assigned...
The CHA2DS2VASc score has been used to evaluate the risk of thromboembolic events in atrial fibrillation. However, because all components are important cardiovascular factors, we decided effectiveness as a long-term predictor for prognosis acute myocardial infarction (AMI) patients.We enrolled 15,681 AMI patients Korean Working Group Acute Myocardial Infarction (KORMI) consecutively and analyzed retrospectively. We divided into four groups according CHADS2VASc (Group I: 0-1, n=3317; II: 2-3,...
Background: Subintimal percutaneous transluminal angioplasty (SIA) is a treatment option for long segment occlusions in the lower limb arteries. In present study factors influencing success and patency following SIA patients with TransAtlantic Inter-Society Consensus (TASC) C D peripheral arterial disease (PAD) were investigated. Methods Results: The 63 consecutive SIAs performed 54 suffering from ischemia TASC lesions. Follow-up consisted of routine office visits pulse examination,...
Left ventricular (LV) remodeling (LVR) after an acute myocardial infarction (AMI) has important clinical implications. We have investigated the prognostic relevance of systolic dyssnchrony as indicator LVR AMI.We enrolled 92 patients (males, 72.8%; mean age, 61.0+/-13.0 years) with AMI who underwent successful percutaneous coronary intervention. analyzed baseline characteristics, laboratory and echocardiographic findings, we performed follow-up echocardiography 6 months AMI. The were divided...
The self-expandable COMPLETE™ stent (Medtronic) has greater elasticity, allowing it to regain its shape after the compression force reduces, and higher trackability, thus is easier maneuver through tortuous vessels, whereas balloon-expandable SCUBA™ radial stiffness can afford more accurate placement without geographic miss, which important in aortoiliac bifurcation lesions. To date, there have been no randomized control trials comparing efficacy safety between self-expanding advanced...
Background and Objectives:The high-sensitivity C-reactive protein (hs-CRP), a marker of inflammation, has been known to be elevated in patients with coronary artery disease.However, there is controversy about the predictive value hs-CRP after acute myocardial infarction (MI).Therefore, we evaluated impact ischemic time on ST-segment elevation (STEMI) who were treated by primary percutaneous intervention (PCI).Subjects Methods: We enrolled 5123 STEMI PCI from Korean Working Group Myocardial...
Obesity is a well-established risk factor for many chronic disorders.However, the effect of weight change after acute myocardial infarction (AMI) not well known.Among consecutive patients who underwent percutaneous coronary intervention between November 2005 and 2007 due to AMI, were overweight (23.0≤ body mass index [BMI]<27.5kg/m 2 , n=341) obese (BMI≥27.5 kg/m n=80) selected analysis.According change, divided into 4 groups: Group I (weight loss＞5%, n=61), II (0%＜weight loss≤5%, n=133),...
Background and Objectives: Triple anti-platelet therapy is known to prevent restenosis after drug-eluting stent (DES) implantation.However, there little available data concerning the efficacy of triple for acute myocardial infarction (AMI).Subjects Methods: We analyzed 528 consecutive patients with AMI undergoing DES implantation between Nov 2005 Apr 2008.We compared clinical outcomes in (group I, n=413: cilostazol combined aspirin clopidogrel at least one month) dual antiplatelet groups II,...
2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD), one of the components Agent Orange, has been reported to be a deadly poison despite its presence at extremely small doses. TCDD is cause various kinds cancers and other harmful effects on humans. However, correlation between exposure acute coronary syndrome (ACS) not yet proven. Thus, we examined ACS through an analysis angiograms from veterans Vietnam War. Two hundred fifty-one consecutive men undergoing owing April 2004 May 2009 Gwangju Veterans...
The effects of statins on insulin resistance and new-onset diabetes are unclear. purpose this study was to evaluate the rosuvastatin adiponectin in patients with mild moderate hypertension. In a randomized, prospective, single-blind study, 53 hypertensive were randomly assigned control group (n=26) or (20 mg once daily) (n=27) during an 8-week treatment period. Both groups showed significant improvements systolic blood pressure flow-mediated dilation (FMD) after 8 weeks treatment....
There have been few randomized control trials comparing the incidence of stent fracture and primary patency among different self-expanding nitinol stents to date. The SMART™ CONTROL (Cordis Corp, Miami Lakes, Florida, United States) has a peak-to-valley bridge inline interconnection, whereas COMPLETE™-SE (Medtronic Vascular, Santa Rosa, California, crowns configured minimize crown-to-crown interaction, increasing stent's flexibility without compromising radial strength. Further, 2011 ESC...